Workflow
New Strong Sell Stocks for June 30th
ZACKS· 2025-06-30 11:05
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:Aegon Ltd. (AEG) is an insurance, pensions and asset management services company. The Zacks Consensus Estimate for its current year earnings has been revised 4.9% downward over the last 60 days.Apogee Enterprises, Inc. (APOG) is a glass and metal products and services company. The Zacks Consensus Estimate for its current year earnings has been revised nearly 8% downward over the last 60 days.Assertio Holdings, Inc. (ASRT) is a special ...
2 High-Yield High-Conviction Blue-Chip Buys For H2 2025
Seeking Alpha· 2025-06-30 11:05
Samuel Smith has a diverse background that includes being lead analyst and Vice President at several highly regarded dividend stock research firms and running his own dividend investing YouTube channel. He is a Professional Engineer and Project Management Professional and holds a B.S. in Civil Engineering & Mathematics from the United States Military Academy at West Point and has a Masters in Engineering from Texas A&M with a focus on applied mathematics and machine learning.Samuel leads the High Yield Inve ...
Top 5 Stocks for July: Momentum-Driven Picks to Watch Now
MarketBeat· 2025-06-30 11:02
Core Insights - The article discusses several stocks that are expected to perform well in July, highlighting their momentum-driven price movements and positive outlooks for growth and cash flow [1] Group 1: Zscaler - Zscaler is noted as the most upgraded stock from Q1, with its cloud-native SaaS cybersecurity services aiding small and medium-sized businesses [1] - The company reported solid growth in the low 20% range, margin strength, and impressive guidance, prompting analysts to raise their forecasts [1][2] - The stock has seen a robust market response, with an approximately 85% gain from recent lows, indicating potential for further price increases [3][4] Group 2: Snowflake - Snowflake's FQ1 earnings report indicates strong business momentum and a sustained outlook for over 20% revenue growth [6][8] - Despite some downgrades, the overall analyst sentiment remains positive, leading to a solid Buy rating and rising consensus price target [7] - The stock is expected to break out of its long-term trading range, with a potential target near $350 by 2026 [8] Group 3: Dave & Buster's - Dave & Buster's is actively working on a business turnaround, with Q1 results showing sequential improvement and an optimistic outlook for growth and profitability [12][13] - Analysts have responded positively, with multiple price target increases following the FQ1 results, indicating a potential 25% gain [13] - The stock is approaching critical resistance levels, with expectations of reaching $40, which could trigger further inflows [14][15] Group 4: Oracle - Oracle has successfully transitioned into the cloud, with its cloud business thriving and expected to see substantial growth in 2026 [18][19] - The company is generating robust cash flow, which is being used for dividends and share buybacks [19] - Analyst trends are positive, with increased coverage and price target revisions suggesting potential for the stock to exceed $300 soon [20] Group 5: Advanced Micro Devices - Advanced Micro Devices is experiencing a rebound driven by AI, with expectations of nearly 40% top-line growth in Q2 [22][23] - The company is positioned for significant market share gains with the upcoming launch of the MI400 product [24] - Analysts have shown strong support through price target increases, indicating potential for a 40% upside [25]
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
CNBC· 2025-06-30 11:00
Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product and the company's separate combination flu and Covid jab.Moderna in May voluntarily withdrew an application seeking approval of its combination shot targeting Covid-19 and influenza, saying it had plans to resubmit it with efficacy data from the phase three trial on its standalone flu vaccine. That decision came afte ...
WuXi Biologics Launches Next-Generation Platform WuXiHigh™2.0 for High-Concentration Biologics with Protein Concentration Reaching 230 mg/mL
Prnewswire· 2025-06-30 11:00
The WuXiHigh™2.0 technology platform harnesses proprietary excipient blends and expertise to enable concentrations up to 230 mg/mL It reduces viscosity by up to 90% while maintaining formulation stability and injectabilitySHANGHAI, June 30, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of WuXiHigh™2.0, a high-throughput formulation development platform designed for high concentration biologi ...
JinkoSolar and ib vogt Partner to Deliver High-Efficiency Tiger Neo Modules for Spain's 513 MWp Segovia Solar Cluster
Prnewswire· 2025-06-30 11:00
MUNICH, June 30, 2025 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced the successful delivery of its high-efficiency Tiger Neo modules to support the construction of Spain's newly inaugurated Segovia solar cluster.Developed by ib vogt, the large-scale project spans approximately 666 hectares in the Castile and León region and comprises four utility-scale solar parks, one of the country's ...
Wesco Publishes 2025 Sustainability Report
Prnewswire· 2025-06-30 11:00
PITTSBURGH, June 30, 2025 /PRNewswire/ -- Wesco International (NYSE:WCC), a leading provider of business-to-business distribution, logistics services and supply chain solutions, issued its annual sustainability report today. The report outlines Wesco's key initiatives for advancing its environmental, social and governance (ESG) goals set in the 2021 report that include reducing scope 1 and 2 greenhouse gas (GHG) emissions by 30%, reducing landfill waste intensity by 15%, achieving a 15% reduction in total r ...
Oncolytics Biotech® Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy
Prnewswire· 2025-06-30 11:00
SAN DIEGO and CALGARY, Alberta, June 30, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the appointment of Andrew Aromando as Chief Business Officer.Mr. Aromando most recently served as Chief Operating Officer at Ambrx Biopharma, where his contributions were instrumental in the $2 billion acquisition of the San Diego-based biotech by Johnson & Johnson. In his role at Oncolytics, Mr. Aromand ...
Labcorp Upgraded To A Buy As Portfolio Grows And Leverage Stays Low
Seeking Alpha· 2025-06-30 10:58
Albert Anthony is the pen name of a Croatian-American business author who is a media contributor on investor platform Seeking Alpha, where he has over +1K followers, & also writes for platforms like Investing dot com and is launching a book on Amazon in 2025 called Financial Markets: The Next Generation. Calling himself part of the new generation of analysts in the financial markets, he comes from a non-traditional financial background having been an analyst in the IT sector for several Fortune 500 companie ...
Why Palo Alto's AI Push Could Rewrite The Rules Of Digital Defense
Seeking Alpha· 2025-06-30 10:43
Group 1 - Cybersecurity vendors are increasingly viewed as essential utilities in the digital economy, yet the market still favors specialized point-tool solutions over comprehensive integrated platforms [1] - Palo Alto Networks is demonstrating the effectiveness of a unified operating system for security, positioning itself as a leader in the cybersecurity space [1] Group 2 - The article highlights the growing importance of cybersecurity in the context of digital transformation and the need for robust security solutions [1]